GIGAGEN INC
- SAN CARLOS, CA 94070-2727
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $29.6M
- Awards on record
- 1
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
GIGAGEN INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About GIGAGEN INC
- Headquarters
- SAN CARLOS, CA 94070-2727
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIHF7MJJDVQQX5
- CAGE626U9
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $29.6M
- Awards on record
- 1
- Top funding agencies
- Office of Assistant Secretary for Preparedness and Response
Awards
75A50124C00049
Recompete 18+ mo: Potential end Nov 30, 2028 (24 months away)NEXT GEN RECOMBINANT POLYCLONAL ANTIBODY DISCOVERY PLATFORM FOR THE DEVELPMENT OF MEDICAL COUNTERMEASURES
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $29.6M
- Period of performance
- Sep 25, 2024 – Nov 30, 2028
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75A50124C00049 NEXT GEN RECOMBINANT POLYCLONAL ANTIBODY DISCOVERY PLATFORM FOR THE DEVELPMENT OF MEDICAL COUNTERMEASURES | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541715 · Q701SPECIALIZED MEDICAL SUPPORT | $29.6M | Sep 25, 2024 – Nov 30, 2028 | Recompete 18+ mo: Potential end Nov 30, 2028 (24 months away) |
Contract vehicles
No contract vehicles on file
Proven teaming graph
Primes it has worked under
No reported sub-awards as a subcontractor.
Subcontractors it has used
- ANTIBODY SOLUTIONS
UEI MCDWNBFRML18
$934.3K
Subcontracted by this company · 1 sub-award · latest Mar 12, 2025
- Office of Assistant Secretary for Preparedness and Response
- “ANTIBODY DISCOVERY”
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · as of Nov 9, 2026 · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 17 awards
- Total awarded
- $10,857,672
- By phase
- SBIR Phase I: 11
- SBIR Phase II: 6
- By agency
- Department of Health and Human Services: 14
- National Science Foundation: 2
- Department of Energy: 1
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2017: 1
- 2016: 2
- 2015: 3
- 2014: 3
- 2013: 1
- 2012: 5
- 2011: 2
Awards (most recent first)
Production Technology for Recombinant Intravenous Immunoglobulin
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $3,000,000
Aug 7, 2017 – Jul 31, 2020
Solicitation PA15-269 (2015) · Topic NIAID
Next-Generation Antibody Discovery and Development Technology
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $1,570,238
Sep 23, 2016 – Aug 31, 2019
Solicitation PAR13-327 (2013) · Topic NCI
Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $1,499,857
Jul 1, 2016 – Jun 30, 2019
- Direct to Phase II
Solicitation PAR14-088 (2014) · Topic NIAID
Production Technology for Recombinant Intravenous Immunoglobulin
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $225,000
Jun 24, 2015 – May 31, 2016
Solicitation PA14-071 (2015) · Topic NIAID
Commercialization of an Advanced Technology for T Cell Receptor Analysis and Engineering
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $265,000
Jun 24, 2015 – May 31, 2016
Solicitation PA16-019 (2016) · Topic NIAID
Recombinant Hyperimmune Gammaglobulin for Pneumococcal Disease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $224,819
May 1, 2015 – Dec 31, 2015
Solicitation PA14-071 (2015) · Topic NIAID
Molecular Kits and Software for Lymphoid Malignancy Work-ups
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $912,746
Jul 1, 2014 – Jun 30, 2016
Solicitation PA13-088 (2014) · Topic 102
B Cell Repertoire Molecular Platform for Antibody Drug Discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $249,077
Solicitation PAR13-327 (2014) · Topic NCI · Research partner: Stub
Therapeutic Antibody Discovery from Pancreatic Cancer B Cell Repertoires
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $217,469
Solicitation PA14-071 (2014) · Topic NCI · Research partner: Stub
Cloud-Based Bioinformatics for Immune Repertoire Analysis
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $1,140,200
Sep 23, 2013 – Jul 22, 2016
Solicitation PA13-088 (2014) · Topic NHGRI
SBIR Phase II: Multiplexed Single Cell Analysis
SBIR Phase II · National Science Foundation · 2012 · $500,000
Sep 1, 2012 – Aug 31, 2014
Solicitation year 2012 · Topic BC · Research partner: Stub
Massively Parallel Single Cell Transcriptomics
SBIR Phase I · Department of Energy · 2012 · $150,000
Feb 20, 2012 – Nov 19, 2012
Solicitation DE-FOA-0000577 (2012) · Topic 05 a · Research partner: Stub
Bioinformatics Data Cleaning for Immune Repertoire Sequencing
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $205,650
Solicitation PA12-088 (2012) · Topic NCI · Research partner: Stub
Massively Parallel Haplotyping
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $189,550
Solicitation PA10-050 (2012) · Topic NHGRI · Research partner: Stub
Cloud-Based Analysis of TCR Repertoire Sequencing Data
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $156,450
Solicitation PA11-096 (2012) · Topic NHGRI · Research partner: Stub
SBIR Phase I: Multiplexed Single Cell Analysis
SBIR Phase I · National Science Foundation · 2011 · $150,000
Jul 1, 2011 – Dec 31, 2011
Solicitation year 2010 · Topic BC · Research partner: Stub
Innovative Molecular Platform for Prenatal Diagnostics
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $201,616
Solicitation PA10-050 (2011) · Topic NICHD · Research partner: Stub
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Primary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
- AC12NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with GIGAGEN INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.